Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$1.73B |
| 2 |
ONC
BeOne Medicines Ltd
ONC
|
+$774M |
| 3 |
Illumina
ILMN
|
+$691M |
| 4 |
DexCom
DXCM
|
+$438M |
| 5 |
Netflix
NFLX
|
+$360M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$3.79B |
| 2 |
Amazon
AMZN
|
+$1.28B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$587M |
| 4 |
Zillow
Z
|
+$400M |
| 5 |
AMTD
TD Ameritrade Holding Corp
AMTD
|
+$264M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 37.71% |
| 2 | Technology | 16.18% |
| 3 | Healthcare | 15.43% |
| 4 | Communication Services | 14.41% |
| 5 | Financials | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Moody's
MCO
$82.7B
| $1.57B | 0.88% |
5,426,323
-107,846
| -2% | -$30.2M |
|
27
Intuitive Surgical
ISRG
$134B
| $1.56B | 0.87% |
5,731,431
+100,245
| +2% | +$24.9M |
|
28
Atlassian
TEAM
$37.8B
| $1.54B | 0.86% |
6,576,802
+78,271
| +1% | +$16.5M |
|
29
Microsoft
MSFT
$3.71T
| $1.53B | 0.85% |
6,860,324
-160,023
| -2% | -$34.4M |
|
30
Teladoc Health
TDOC
$1.3B
| $1.45B | 0.81% |
7,238,667
+996,628
| +16% | +$203M |
|
31
Chegg
CHGG
$103M
| $1.44B | 0.8% |
15,985,840
+249,377
| +2% | +$19.8M |
|
32
NovoCure
NVCR
$1.91B
| $1.43B | 0.8% |
8,261,075
+136,430
| +2% | +$18.7M |
|
33
Carvana
CVNA
$77.9B
| $1.39B | 0.77% |
29,030,805
+571,975
| +2% | +$26.1M |
|
34
Elevance Health
ELV
$85.5B
| $1.27B | 0.71% |
3,951,669
-91,681
| -2% | -$28.1M |
|
35
Salesforce
CRM
$158B
| $1.25B | 0.7% |
5,614,737
+101,177
| +2% | +$24.6M |
|
36
Alnylam Pharmaceuticals
ALNY
$29.3B
| $1.19B | 0.66% |
9,132,422
+240,934
| +3% | +$32.2M |
|
37
Ryanair
RYAAY
$31.3B
| $1.15B | 0.64% |
26,231,598
-473,225
| -2% | -$18.6M |
|
|
ONC
38
BeOne Medicines Ltd
ONC
$38.7B
| $1.1B | 0.61% |
4,247,827
+2,812,638
| +196% | +$774M |
|
39
KE Holdings
BEKE
$18.8B
| $1.09B | 0.6% |
17,631,431
+2,901,701
| +20% | +$193M |
|
40
Roku
ROKU
$22.7B
| $1.04B | 0.58% |
3,132,766
+649,128
| +26% | +$170M |
|
41
Denali Therapeutics
DNLI
$3.94B
| $1.02B | 0.57% |
12,190,256
+1,363,078
| +13% | +$82.4M |
|
42
Thermo Fisher Scientific
TMO
$220B
| $1.02B | 0.57% |
2,181,583
-56,300
| -3% | -$26.4M |
|
43
Twilio
TWLO
$36.6B
| $1.01B | 0.56% |
2,992,072
-1,913
| -0.1% | -$598K |
|
|
44
Zillow
Z
$7.56B
| $1.01B | 0.56% |
7,745,166
-3,617,908
| -32% | -$400M |
|
45
Appian
APPN
$2.54B
| $996M | 0.55% |
6,142,402
+242,039
| +4% | +$27.1M |
|
|
ABMD
46
DELISTED
Abiomed Inc
ABMD
| $986M | 0.55% |
3,041,827
+96,574
| +3% | +$26.7M |
|
47
Arthur J. Gallagher & Co
AJG
$63.6B
| $985M | 0.55% |
7,962,276
-215,131
| -3% | -$24.5M |
|
48
TSMC
TSM
$2.18T
| $974M | 0.54% |
8,931,444
-746,675
| -8% | -$70.8M |
|
49
Teradyne
TER
$59.3B
| $948M | 0.53% |
7,906,303
-166,002
| -2% | -$17M |
|
50
MarketAxess Holdings
MKTX
$5.72B
| $909M | 0.51% |
1,593,978
+16,426
| +1% | +$8.95M |
|
Similar funds
Baillie Gifford & Co's Q4 2020 Portfolio in Review
As of Q4 2020, Baillie Gifford & Co held 443 positions worth $180B, up 24% from $145B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Baillie Gifford & Co's Q4 2020 filing shows 192 new, 135 increased, 77 reduced and 14 closed positions. Its largest new stake was Kingsoft Cloud Holdings: 7,346,496 shares worth $320M. The largest sale was Tesla, an estimated $3.79B.
By sector, the portfolio is most concentrated in Consumer Discretionary at 38% of assets, up from 37% a quarter earlier, followed by Technology and Healthcare.
- Baillie Gifford & Co's largest Q4 2020 buy was Kingsoft Cloud Holdings: 7,346,496 shares worth $320M.
- Baillie Gifford & Co added most to Moderna in Q4 2020, an estimated $1.73B increase.
- Baillie Gifford & Co's biggest Q4 2020 reduction was Tesla, cutting an estimated $3.79B.
- Baillie Gifford & Co fully exited TD Ameritrade Holding Corp in Q4 2020, selling an estimated $264M.
- Baillie Gifford & Co's ten largest holdings make up 43% of its $180B portfolio in Q4 2020.
- Baillie Gifford & Co opened 192 new positions and closed 14 in Q4 2020.
- Baillie Gifford & Co's portfolio value rose 24% quarter-over-quarter to $180B.
Based on Baillie Gifford & Co's 13F filing for Q4 2020, filed 10 Feb 2021.